Medulloblastoma
📧 Sign up to get email alerts when something new happens for Medulloblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-11-05Clinical Trial Update: Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia [Phase 1]
Phase 1 study of RO4929097, a gamma-secretase inhibitor, in pediatric patients with relapsed or refractory solid tumors, CNS tumors, lymphom…
-
CLINICAL_TRIALS trial_result · 2014-08-01Clinical Trial Update: Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma [Phase 3]
A Phase 3 trial investigated radiation therapy plus combination chemotherapy in children with medulloblastoma; the study has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-25Clinical Trial Update: Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma [Phase 2]
Phase 2 trial evaluating etoposide plus radiation therapy followed by combination chemotherapy in children with newly diagnosed advanced med…
-
CLINICAL_TRIALS trial_result · 2014-07-24Clinical Trial Update: Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors [Phase 2]
Phase 2 clinical trial evaluating combination chemotherapy followed by bone marrow or peripheral stem cell transplantation in patients with …
-
CLINICAL_TRIALS trial_result · 2014-06-24Clinical Trial Update: Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma [Phase 3]
A Phase 3 clinical trial update investigates radiation therapy plus combination chemotherapy for children with medulloblastoma; the current …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-04-02Clinical Trial Update: GDC-0449 in Treating Young Patients With Medulloblastoma That is Recurrent or Did Not Respond to Previous Treatment [Phase 1]
A Phase 1 study evaluating GDC-0449 (vismodegib) in young patients with recurrent or treatment-refractory medulloblastoma has been completed…
-
CLINICAL_TRIALS trial_result · 2014-02-27Clinical Trial Update: Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor [Phase 3]
Phase 3 clinical trial evaluating treatment for newly diagnosed medulloblastoma, supratentorial PNET, or atypical teratoid rhabdoid tumor; s…
-
CLINICAL_TRIALS trial_result · 2013-10-08Clinical Trial Update: Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem Glioma [Phase 2]
Phase 2 clinical trial update evaluating tipifarnib in pediatric patients with recurrent or progressive brain tumors has completed, reportin…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors [Phase 1]
This Phase 1 trial evaluates the combination of temozolomide and O6-benzylguanine in pediatric patients with recurrent brain tumors.
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors [Phase 1]
A Phase 1 clinical trial evaluated lenalidomide in young patients with recurrent, progressive, or refractory central nervous system tumors. …
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Cilengitide in Treating Children With Refractory Primary Brain Tumors [Phase 1]
Phase 1 trial of cilengitide in children with refractory primary brain tumors has completed; the study explored safety, dosing, and tolerabi…
-
CLINICAL_TRIALS trial_result · 2013-08-09Clinical Trial Update: Combination Chemotherapy Followed by Second-Look Surgery and Radiation Therapy in Treating Children With Nonmetastatic Medulloblastoma or Primitive Neuroectodermal Tumor [Phase 3]
Phase 3 trial evaluating combination chemotherapy followed by second-look surgery and radiation for untreated childhood medulloblastoma or s…
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Combination Chemotherapy, Surgery or Radiation Therapy, and Peripheral Stem Cell Transplant in Treating Patients With Recurrent Medulloblastoma or Primitive Neuroectodermal and Pineal Tumors [Phase 2]
A Phase 2 trial evaluating combination chemotherapy, surgery or radiation therapy, and peripheral stem cell transplantation for patients wit…
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: Combination Chemotherapy Followed by Radiation Therapy in Treating Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma [Phase 2]
Phase 2 study of combination chemotherapy followed by radiation therapy in children with medulloblastoma, supratentorial primitive neuroecto…
-
CLINICAL_TRIALS trial_result · 2013-07-02Clinical Trial Update: Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas [Phase 1]
A Phase 1 study of flavopiridol in children with relapsed or refractory solid tumors or lymphomas has completed, focusing on safety and dosi…
-
CLINICAL_TRIALS trial_result · 2013-06-14Clinical Trial Update: Irinotecan in Treating Children With Refractory Solid Tumors [Phase 2]
A Phase 2 trial evaluating irinotecan in children with refractory solid tumors has completed, with results reported by the Children's Oncolo…
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors [Phase 1]
Phase 1 study evaluating the combination of erlotinib and temozolomide in pediatric patients with recurrent or refractory solid tumors has c…
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors [Phase 1]
Phase 1 evaluation of vorinostat in combination with temozolomide in children with relapsed or refractory primary brain tumors or spinal cor…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia [Phase 1]
Phase 1 trial evaluating FR901228 in pediatric patients with refractory or recurrent solid tumors or leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors [Phase 1]
This document is a terminated Phase 1 trial update evaluating PET imaging with 18F-EF5 to measure oxygenation in brain tumor cells of adults…
-
CLINICAL_TRIALS trial_result · 2013-01-15Clinical Trial Update: Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma [Phase 2]
Phase 2 trial evaluating bevacizumab combined with irinotecan in pediatric patients with recurrent or progressive brain tumors including gli…
-
CLINICAL_TRIALS trial_result · 2012-11-07Clinical Trial Update: Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor [Phase 2]
A completed Phase 2 study by St. Jude evaluated chemotherapy, radiation therapy, and peripheral stem cell transplantation in children newly …
-
CLINICAL_TRIALS trial_result · 2012-02-17Clinical Trial Update: Combination of Irinotecan and Temozolomide in Children With Brain Tumors. [Phase 2]
Phase 2 trial evaluating the combination of irinotecan and temozolomide in children with brain tumors (glioma and medulloblastoma) has compl…
-
CLINICAL_TRIALS trial_result · 2012-02-06Clinical Trial Update: Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System Tumors [Phase 1, Phase 2]
This clinical trial update summarizes the results of a Phase 1/2 study evaluating lapatinib in pediatric patients with recurrent or refracto…
-
CLINICAL_TRIALS trial_result · 2011-02-23Clinical Trial Update: A Study of Pemetrexed in Children With Recurrent Cancer [Phase 2]
Pemetrexed was studied in a Phase 2 trial in children with recurrent cancer across several pediatric tumor types, including osteosarcoma and…